Global Vinpocetine Market Insights, Research, Forecast to 2025

Published On: Aug 2019

Format: PDF

Publisher: QY Research

Pages: 112

Report ID: 347716

Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis
The global Vinpocetine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Vinpocetine market based on company, product type, end user and key regions.

This report studies the global market size of Vinpocetine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Vinpocetine in these regions.
This research report categorizes the global Vinpocetine market by top players/brands, region, type and end user. This report also studies the global Vinpocetine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Gedeon Richter
Runhong
Sun Pharma
WZT
PUDE
Welman
ZhiTong
Liaoning Zhiying
COVEX
Northeast Pharma
Micro Labs

Market size by Product
Tablet
Injection
Market size by End User
Household
Hospital

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Vinpocetine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Vinpocetine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Vinpocetine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Vinpocetine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Vinpocetine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Vinpocetine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Vinpocetine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Vinpocetine Market Size Growth Rate by Product
1.4.2 Tablet
1.4.3 Injection
1.5 Market by End User
1.5.1 Global Vinpocetine Market Size Growth Rate by End User
1.5.2 Household
1.5.3 Hospital
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Vinpocetine Market Size
2.1.1 Global Vinpocetine Revenue 2014-2025
2.1.2 Global Vinpocetine Sales 2014-2025
2.2 Vinpocetine Growth Rate by Regions
2.2.1 Global Vinpocetine Sales by Regions
2.2.2 Global Vinpocetine Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Vinpocetine Sales by Manufacturers
3.1.1 Vinpocetine Sales by Manufacturers
3.1.2 Vinpocetine Sales Market Share by Manufacturers
3.1.3 Global Vinpocetine Market Concentration Ratio (CR5 and HHI)
3.2 Vinpocetine Revenue by Manufacturers
3.2.1 Vinpocetine Revenue by Manufacturers (2014-2019)
3.2.2 Vinpocetine Revenue Share by Manufacturers (2014-2019)
3.3 Vinpocetine Price by Manufacturers
3.4 Vinpocetine Manufacturing Base Distribution, Product Types
3.4.1 Vinpocetine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Vinpocetine Product Type
3.4.3 Date of International Manufacturers Enter into Vinpocetine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Vinpocetine Sales by Product
4.2 Global Vinpocetine Revenue by Product
4.3 Vinpocetine Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Vinpocetine Breakdown Data by End User

6 North America
6.1 North America Vinpocetine by Countries
6.1.1 North America Vinpocetine Sales by Countries
6.1.2 North America Vinpocetine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Vinpocetine by Product
6.3 North America Vinpocetine by End User

7 Europe
7.1 Europe Vinpocetine by Countries
7.1.1 Europe Vinpocetine Sales by Countries
7.1.2 Europe Vinpocetine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Vinpocetine by Product
7.3 Europe Vinpocetine by End User

8 Asia Pacific
8.1 Asia Pacific Vinpocetine by Countries
8.1.1 Asia Pacific Vinpocetine Sales by Countries
8.1.2 Asia Pacific Vinpocetine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Vinpocetine by Product
8.3 Asia Pacific Vinpocetine by End User

9 Central & South America
9.1 Central & South America Vinpocetine by Countries
9.1.1 Central & South America Vinpocetine Sales by Countries
9.1.2 Central & South America Vinpocetine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Vinpocetine by Product
9.3 Central & South America Vinpocetine by End User

10 Middle East and Africa
10.1 Middle East and Africa Vinpocetine by Countries
10.1.1 Middle East and Africa Vinpocetine Sales by Countries
10.1.2 Middle East and Africa Vinpocetine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Vinpocetine by Product
10.3 Middle East and Africa Vinpocetine by End User

11 Company Profiles
11.1 Gedeon Richter
11.1.1 Gedeon Richter Company Details
11.1.2 Company Business Overview
11.1.3 Gedeon Richter Vinpocetine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Gedeon Richter Vinpocetine Products Offered
11.1.5 Gedeon Richter Recent Development
11.2 Runhong
11.2.1 Runhong Company Details
11.2.2 Company Business Overview
11.2.3 Runhong Vinpocetine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Runhong Vinpocetine Products Offered
11.2.5 Runhong Recent Development
11.3 Sun Pharma
11.3.1 Sun Pharma Company Details
11.3.2 Company Business Overview
11.3.3 Sun Pharma Vinpocetine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Sun Pharma Vinpocetine Products Offered
11.3.5 Sun Pharma Recent Development
11.4 WZT
11.4.1 WZT Company Details
11.4.2 Company Business Overview
11.4.3 WZT Vinpocetine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 WZT Vinpocetine Products Offered
11.4.5 WZT Recent Development
11.5 PUDE
11.5.1 PUDE Company Details
11.5.2 Company Business Overview
11.5.3 PUDE Vinpocetine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 PUDE Vinpocetine Products Offered
11.5.5 PUDE Recent Development
11.6 Welman
11.6.1 Welman Company Details
11.6.2 Company Business Overview
11.6.3 Welman Vinpocetine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Welman Vinpocetine Products Offered
11.6.5 Welman Recent Development
11.7 ZhiTong
11.7.1 ZhiTong Company Details
11.7.2 Company Business Overview
11.7.3 ZhiTong Vinpocetine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 ZhiTong Vinpocetine Products Offered
11.7.5 ZhiTong Recent Development
11.8 Liaoning Zhiying
11.8.1 Liaoning Zhiying Company Details
11.8.2 Company Business Overview
11.8.3 Liaoning Zhiying Vinpocetine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Liaoning Zhiying Vinpocetine Products Offered
11.8.5 Liaoning Zhiying Recent Development
11.9 COVEX
11.9.1 COVEX Company Details
11.9.2 Company Business Overview
11.9.3 COVEX Vinpocetine Sales, Revenue and Gross Margin (2014-2019)
11.9.4 COVEX Vinpocetine Products Offered
11.9.5 COVEX Recent Development
11.10 Northeast Pharma
11.10.1 Northeast Pharma Company Details
11.10.2 Company Business Overview
11.10.3 Northeast Pharma Vinpocetine Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Northeast Pharma Vinpocetine Products Offered
11.10.5 Northeast Pharma Recent Development
11.11 Micro Labs

12 Future Forecast
12.1 Vinpocetine Market Forecast by Regions
12.1.1 Global Vinpocetine Sales Forecast by Regions 2019-2025
12.1.2 Global Vinpocetine Revenue Forecast by Regions 2019-2025
12.2 Vinpocetine Market Forecast by Product
12.2.1 Global Vinpocetine Sales Forecast by Product 2019-2025
12.2.2 Global Vinpocetine Revenue Forecast by Product 2019-2025
12.3 Vinpocetine Market Forecast by End User
12.4 North America Vinpocetine Forecast
12.5 Europe Vinpocetine Forecast
12.6 Asia Pacific Vinpocetine Forecast
12.7 Central & South America Vinpocetine Forecast
12.8 Middle East and Africa Vinpocetine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Vinpocetine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer